Cannonball Pulmonary Opacities Disclosing a Granulomatosis With ...
What Is Conjunctival Chemosis?
The conjunctiva is the clear membrane that covers the white part of the eye. Conjunctival chemosis is a swelling of the membrane. It can look like a big blister on the eyeball. The eyes may be yellowish and watery. Chemosis can get so severe that it is hard to close the eye.
Although it can be unsightly, chemosis is usually easy to treat, although sometimes takes time to totally resolve. Also, the condition is not contagious as some other eye conditions can be. The best solution is prevention. If you understand what causes chemosis, you may be able to avoid repeated episodes.
Allergies are the most common cause of conjunctival chemosis. Chemosis can develop after surgery on the eye. It can be caused by conjunctivitis, commonly known as pinkeye, and by a few other conditions.
When allergies make the eyes red and swollen, the resulting condition is sometimes called allergic conjunctivitis. Studies suggest that around 40% of the population in developed countries may have this condition. The eye irritation can lead to chemosis.
Typical allergy symptoms include:
When chemosis is triggered by allergies, doctors may treat the cause and the symptoms. They may suggest cold compresses and artificial tears to ease the symptoms of chemosis. To attack the cause, they may use antihistamines and other medicines that tamp down allergic reactions.
Another treatment involves the use of steroids. Some doctors are using steroids earlier in the course of chemosis. They want to stop what is called an inflammatory or allergic cascade, where one reaction leads to another and then to another.
The eye infection known as conjunctivitis, or pinkeye, can lead to conjunctival chemosis. Treating the conjunctivitis should make the chemosis go away.
Some cases of pinkeye are bacterial, and some are viral. Bacterial conjunctivitis is treated with antibiotic eye drops. The usual course of treatment is 7 to 10 days.
Viral conjunctivitis usually requires no treatment. Usually, the eyes will be better in a week or so. Antibiotic eye drops are not effective against a virus. The antiviral eye drops used for some other eye conditions do not work on pinkeye.
It's difficult to distinguish between the two types of pinkeye, so some doctors routinely prescribe antibiotic ointments or drops. In severe cases of viral conjunctivitis, doctors may prescribe steroid drops.
Since both types are infectious, it's important to prevent them from spreading. To contain the infection, try these measures:
Chemosis can also follow eyelid surgery or other trauma to the eyelid. The most common cause is blepharoplasty – surgery to repair drooping eyelids.
Certain conditions are risk factors for this type of chemosis. For example, chemosis may be more likely if the lower lid is slack or doesn't close well. Doctors may address some of these problems before they operate.
Chemosis can develop in the middle of surgery. Doctors can use certain surgical techniques to stop the chemosis during the surgery. They may use eye drops during the surgery to manage the chemosis.
Some cases of chemosis appear after the surgery. They can be mild, moderate, or severe. Doctors treat them with drops, ointments, the use of an eye patch, and other measures. Sometimes the chemosis persists and further surgery is necessary.
Thyroid eye disease (TED) causes inflammation of the eyes and the tissues around the eyes, often resulting in chemosis. The usual cause of TED is Graves' disease, an autoimmune disorder in which the body attacks its own tissues. Graves' ophthalmopathy is another term for TED.
Graves' disease causes the body to produce too much thyroid hormone. Those with TED must control their thyroid levels carefully. Even when they do, they may still have eye problems.
These problems may include:
Doctors evaluate the severity of TED by looking at seven signs or symptoms. Chemosis is one of those signs.
TED is mostly treated through lifestyle interventions. It is very important that those with TED not smoke and that they practice other good health habits.
They can relieve some symptoms by wearing sunglasses and using treatments for dry eyes. They may ease swelling around the eyes by sleeping with the head elevated and by reducing sodium in the diet. Supplementing with selenium may also help.
Angioedema is an allergic reaction that usually occurs around the eyes or mouth. It causes swelling beneath the skin. When it forms around the eyes, it can trigger chemosis.
Hives – large welts on the skin – can occur with angioedema. Both angioedema and hives usually clear up on their own. Treatment with antihistamines may ease the discomfort. Occasionally, parts of the mouth or throat will swell and interfere with breathing. This is an emergency calling for immediate medical care.
Angioedema can be triggered by:
Other occasional triggers for angioedema include sunlight, tight clothing, exercise, hot water, and insect bites.
If you have a conjunctival cyst, you may be able to see it. It looks like a clear blister or bubble on the eye. You may have extra tears and feel as if you have something in your eye. Sometimes, you might not notice any symptoms at all.
People who have conjunctival cysts often go to the doctor when they notice the cyst getting larger. The cyst may also become so noticeable that it is a cosmetic issue. Rarely, the cysts may cause blurred vision or affect how well your eyeball moves.
Causes of conjunctival cysts: Chemicals, allergies, and dry air can irritate the conjunctiva, leading to conjunctival cysts.
Conjunctival cyst treatment: Sometimes, conjunctival cysts go away on their own. Doctors often advise waiting to see if this happens. To make your eye feel better in the meantime, you can use:
The simplest thing that your doctor can do is to drain the cyst. Doctors can also remove them but there is a chance they can come back. Another method for dealing with conjunctival cysts involves using plasma, an ionized gas produced by heating.
What Are The Symptoms Of Viral Pneumonia?
Viral pneumonia is pneumonia that develops as a result of a viral infection in the lungs. Symptoms may include a fever, a cough, shortness of breath, chills, fatigue, and more.
The symptoms of viral pneumonia are often similar to those of bacterial pneumonia, but, depending on the virus responsible, there may be a few additional symptoms.
A wide range of viruses can cause viral pneumonia, including influenza and coronaviruses, such as SARS-CoV-2, which causes COVID-19.
Viral pneumonia is often mild, but in rare cases, it can be life threatening.
Read on to learn more about the symptoms, causes, and treatment of viral pneumonia.
The symptoms of viral pneumonia can range in severity and may include the following:
Some people with viral pneumonia may also have a sore throat or a headache, depending on the underlying cause of the infection.
Viral pneumonia tends to present differently in each age group.
Young children with viral pneumonia generally have mild symptoms that gradually worsen. A child with viral pneumonia may develop noticeable wheezing, and their skin and lips often take on a blue tint due to a lack of oxygen. They are also likely to lose their appetite.
On the other hand, adults over the age of 65 years may experience abnormally low body temperatures, confusion, and dizziness.
A wide range of viruses can cause viral pneumonia, including:
Viruses spread easily when affected people sneeze or cough. A person can also get the infection if they come into contact with a contaminated surface.
Coronaviruses, a large family of viruses that cause respiratory illness, can lead to viral pneumonia. They include SARS-CoV-2, the virus that causes COVID-19.
The World Health Organization (WHO) declared the viral outbreak a pandemic on March 11, 2020.
According to the WHO, most reported cases are relatively mild — 81% of people have illness that causes no complications, while 14% will develop serious illness and need oxygen therapy, and 5% will need treatment in an intensive care unit.
Severe pneumonia is among the most common complications resulting from severe COVID-19. It may develop by the end of the first week of infection.
People with preexisting health conditions and older adults are more likely to develop severe pneumonia from SARS-CoV-2.
The situation is still developing, so these findings and figures may change.
For live updates on the latest developments regarding the novel coronavirus and COVID-19, click here.
Viral pneumonia can affect anyone, as the viruses that cause it are very contagious.
However, the following factors may increase a person's risk of developing viral pneumonia:
Pneumonia is an infection in the lungs. Doctors classify pneumonia according to its cause. The usual causes of pneumonia include:
Bacterial and viral pneumonia are more common than pneumonia resulting from fungal infections.
Bacteria such as Streptococcus pneumoniae cause bacterial pneumonia. This type of pneumonia is usually more severe than viral pneumonia.
The symptoms of bacterial pneumonia may include:
Viral pneumonia may have some of the same symptoms, but the symptoms tend to be less severe.
Bacterial pneumonia requires treatment with antibiotics. Antibiotics do not help treat viral pneumonia unless there is a secondary bacterial cause.
A doctor will be able to diagnose viral pneumonia.
They will generally begin by asking about any symptoms and carrying out a physical examination. As part of the examination, the doctor will listen to the lungs for any abnormal sounds that may indicate pneumonia.
These sounds may include crackling in the lungs or wheezing while breathing. A doctor will also check for a rapid heart rate and decreased airflow.
If the doctor suspects that pneumonia may be present, they are likely to order some of the following tests to confirm the diagnosis:
The tests that the doctor decides to order will depend on the severity of a person's symptoms and whether they are in one of the higher risk groups.
People with a higher risk of developing pneumonia should see a doctor or visit an emergency room immediately if they develop flu-like symptoms alongside any of the following:
Pneumonia can be extremely serious in higher risk individuals. These people will need immediate treatment for the best outcome.
The viruses that cause viral pneumonia are contagious. During the cold and flu season, a person can take steps to stay healthy. These steps may protect against viral pneumonia and other viral illnesses.
Some techniques that people can use to try to prevent getting sick include:
Most people with viral pneumonia recover within a few weeks. However, some people may take several weeks to recover fully, especially those who have a weakened immune system or are over the age of 65 years.
While viral pneumonia can be contagious, a person can practice good hygiene and self-care to lower their risk of getting the infection.
Conjunctivitis Treatment Market Outlook: Key Insights And Forecasts For 2023
(MENAFN- EIN Presswire)Conjunctivitis Treatment Market
Conjunctivitis treatment market was valued at $4.2 billion in 2021, and is estimated to reach $6.1 billion by 2031, growing at a CAGR of 3.8% from 2022 to 2031.
PORTLAND, OREGON, UNITED STATES, May 29, 2023 /einpresswire.Com / -- The global conjunctivitis treatment market was valued at $4.2 billion in 2021 and is projected to reach $6.1 billion by 2031, growing at a CAGR of 3.8% from 2022 to 2031.
Conjunctivitis Treatment Market TrendsIncreasing prevalence of conjunctivitis.Shift towards targeted therapies based on the cause.Growing use of combination therapies for comprehensive treatment.Rising adoption of anti-inflammatory agents to manage inflammation.Development of novel treatment options and formulations.Increasing preference for over-the-counter (OTC) treatments.
Download the Exclusive Sample Report PDF Here @
The COVID-19 pandemic has had an impact on the conjunctivitis treatment market in several ways:Changes in healthcare seeking behavior: During the pandemic, many individuals postponed non-essential visits to healthcare facilities, including eye clinics. This led to a decrease in the number of people seeking medical attention for conjunctivitis and other eye conditions, affecting the demand for conjunctivitis treatments.
Increased focus on infection control: Given that conjunctivitis can be caused by viral or bacterial infections, the importance of infection control measures was emphasized during the COVID-19 pandemic. This included frequent handwashing, avoiding touching the face and eyes, and practicing good hygiene. These measures aimed to reduce the risk of infection transmission, including conjunctivitis.
Impact on clinical trials and research: The COVID-19 pandemic affected the conduct of clinical trials and research activities in various therapeutic areas, including ophthalmology. This disruption may have slowed down the development and introduction of new conjunctivitis treatment options and innovations.
Shift towards telemedicine and remote consultations: To minimize in-person contact and reduce the risk of COVID-19 transmission, telemedicine and remote consultations became more prevalent during the pandemic. This approach allowed healthcare providers to assess and provide guidance on conjunctivitis cases remotely. However, the ability to diagnose and treat certain types of conjunctivitis effectively through remote consultations may be limited.
Procure Complete Report (220 Pages PDF with Insights, Charts, Tables, and Figures)
Key Players-Abbvie IncAjanta Pharma LimitedAFT PharmaceuticalsAlembic Pharmaceuticals LtdBausch Health Companies IncCipla, Inc.Grevis Pharmaceutical Private LimitedIndoco Remedies Ltd.Jabs Biotech Pvt. Ltd.JAWA Pharmaceuticals Pvt. LtdJohnson & Johnson Services IncNovartis AGOcular Therapeutics, IncSanten Pharmaceuticals Co. Ltd.Spectra Vision Care Pvt. LtdSun Pharmaceuticals Industries LtdTeva Pharmaceutical Industries Ltd
Drug ClassAntibioticsAntiviralAnti-allergicArtificial Tears
Disease TypeAllergic ConjunctivitisBacterial ConjunctivitisViral Conjunctivitis
Have Any Query? Ask Our Expert @:
Key findings of the studyOn the basis of disease type, the allergic conjunctivitis segment held 4.3% share in the global market in 2021.On the basis of drug class, the anti-allergic segment held the largest market share in 2021, and is expected to remain dominant throughout the forecast period.On the basis of distribution channel, the hospital pharmacy segment held the largest market share in 2021, and is expected to remain dominant throughout the forecast period.Region wise, North-America is expected to experience the highest market share during the forecast period.
Key Benefits For StakeholdersThis report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the conjunctivitis treatment market analysis from 2021 to 2031 to identify the prevailing Conjunctivitis Treatment Market opportunity.
The market research is offered along with information related to key drivers, restraints, and opportunities.
Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
In-depth analysis of the conjunctivitis treatment market segmentation assists to determine the prevailing market opportunities.
Major countries in each region are mapped according to their revenue contribution to the global market.
Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
The report includes the analysis of the regional as well as global conjunctivitis treatment market trends, key players, market segments, application areas, and market growth strategies.
Other Top Trending Reports in Healthcare Industry –Hepatitis C Testing MarketSterility Indicators MarketMedical Device Affairs Outsourcing Market
email us hereDavid CorreaAllied Analytics LLP+ 1-800-792-5285
MENAFN29052023003118003196ID1106339100
Legal Disclaimer:MENAFN provides the information "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.
Comments
Post a Comment